Dr. Nathan Stasko | CEO, Vast Therapeutics – Nitric Oxide Innovation in Respiratory Health

from Executive Insights for Life Sciences Innovators · host GeneCoda® Executive Search

In this episode of Executive Insights for Life Sciences Innovators, we speak with Dr. Nathan Stasko, CEO of Vast Therapeutics, about the company’s journey with nitric oxide technology in respiratory therapeutics. Dr. Stasko shares the challenges of advancing novel drug delivery approaches, lessons learned in building a biotech startup, and his perspective on innovation in life sciences.Learn more at genecoda.com.This conversation was originally recorded and streamed on YouTube Live on February 7th, 2025.

Episode metadata supplied by the publisher feed · Published Sep 8, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Dr. Nathan Stasko | CEO, Vast Therapeutics – Nitric Oxide Innovation in Respiratory Health

0:00 26:06

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Executive Insights for Life Sciences Innovators?

This episode is 26 minutes long.

When was this Executive Insights for Life Sciences Innovators episode published?

This episode was published on September 8, 2025.

Can I download this Executive Insights for Life Sciences Innovators episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!